Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases.

Abstract

Perinatal asphyxia (PA) still constitutes a common complication involving a large number of infants with or without congenital heart diseases (CHD). PA affects 0.2-0.6% of full-term neonates, 20% of which suffer mortal hypoxic-ischemic encephalopathy, and among survivors 25% exhibit permanent consequences at neuropsychological level. Each year, about one… (More)

Topics

Cite this paper

@article{Abella2015BiochemicalMF, title={Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases.}, author={Ra{\'u}l Felipe Abella and Alessandro Varrica and Angela Satriano and Guido Tettamanti and Gabriele Pelissero and Antonio Gavilanes and Luc J. I. Zimmermann and Hans J. S. Vles and Maria Chiara Strozzi and Francesca Romana Pluchinotta and Diego Gazzolo}, journal={CNS & neurological disorders drug targets}, year={2015}, volume={14 1}, pages={12-23} }